↓ Skip to main content

The effects of curcumin as dietary supplement for patients with COVID-19: A systematic review of randomized clinical trials

Overview of attention for article published in Drug Discoveries & Therapeutics, February 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#8 of 295)
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter
23 X users
facebook
1 Facebook page
video
1 YouTube creator

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The effects of curcumin as dietary supplement for patients with COVID-19: A systematic review of randomized clinical trials
Published in
Drug Discoveries & Therapeutics, February 2022
DOI 10.5582/ddt.2022.01017
Pubmed ID
Authors

Basel Abdelazeem, Ahmed K Awad, Merihan A Elbadawy, Nouraldeen Manasrah, Bilal Malik, Amman Yousaf, Sarah Alqasem, Sandi Banour, Sarah Magdy Abdelmohsen

X Demographics

X Demographics

The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 13%
Student > Ph. D. Student 3 13%
Researcher 3 13%
Student > Postgraduate 2 9%
Professor 2 9%
Other 3 13%
Unknown 7 30%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 17%
Biochemistry, Genetics and Molecular Biology 3 13%
Nursing and Health Professions 2 9%
Medicine and Dentistry 2 9%
Chemistry 2 9%
Other 3 13%
Unknown 7 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2023.
All research outputs
#2,178,908
of 25,411,814 outputs
Outputs from Drug Discoveries & Therapeutics
#8
of 295 outputs
Outputs of similar age
#52,201
of 450,216 outputs
Outputs of similar age from Drug Discoveries & Therapeutics
#1
of 5 outputs
Altmetric has tracked 25,411,814 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 295 research outputs from this source. They receive a mean Attention Score of 3.5. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,216 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them